近日，杭州全诊医学科技有限公司（以下简称 "全诊医学" ）正式宣布完成数千万元B+轮融资。本轮融资 由 普华资本 领投， 常金控 和 杭州人才基金 跟投， 探针资本 担任独家财务顾问。所筹资金将投入核 心产品"全诊医学大模型及临床应用"的深度研发，加速面向医院和医生的合作推广，并启动海外市场 拓展计划。 此次融资是全诊医学约一年时间完成的第三轮融资，不仅刷新了国内医疗大模型企业融资速度纪录，也 清晰展现了资本市场对医疗AI的关注重点，已从单纯的技术竞速转向了对商业化落地能力与临床实际价 值的深度考量。 # 公 司简介 ： 从 临 床 医 生 到A I 创 新 者 全诊医学成立于杭州，是中国最早专注医疗大模型后训练与临床落地的创新企业之一。公司以"让AI增强医生 能力"为核心使命，长期致力于在医疗文书自动化、临床决策支持、患者服务等关键场景实现AI的系统化赋 能。 公司创始人 薛翀博士 拥有"临床医生+AI研究者"的双重背景。他毕业于中国医学科学院北京协和医学院，曾 在浙江大学医学院附属第二医院任职泌尿外科医生，并在美国约翰·霍普金斯大学医院从事人工智能与机器人 外科手术研究。这一跨界经历使他深刻理解AI在医疗 ...

Core Insights - Hangzhou Quanzhen Medical Technology Co., Ltd. has completed a Series B financing round of 100 million RMB, with strategic investments from Innovation Medical and Good Doctor Group expected in 2024 and 2025 respectively [2] - The company's flagship product, Trizen AI, has seen a tenfold increase in contract amounts with hospitals from January to October 2025 compared to the entire year of 2024, with an expected year-on-year growth of 12-15 times [2] Company Overview - Quanzhen Medical is one of the earliest companies in China focusing on post-training and clinical application of medical large models, aiming to enhance doctors' capabilities through AI [2] - The founder, Dr. Xue Chong, has a dual background as a clinical doctor and AI researcher, emphasizing that AI should assist rather than replace doctors [2] Product and Technology - Trizen AI is the first intelligent medical record and clinical assistance system in China, featuring automatic medical record generation, clinical decision support, and patient service [5] - The system improves medical record writing efficiency by over 65% and supports various types of medical documents, outperforming similar products in accuracy and language logic [5] - Quanzhen Medical is expanding its product from a single medical record tool to a comprehensive "AI doctor assistant" platform, covering the entire patient care process [5] Technical System - The company has established a complete "foundation-model-application" technical system since 2023, focusing on post-training methods tailored for medical scenarios [6] - Trizen AI utilizes localized large model deployment, compressing general models into specialized medical models with 1 to 10 billion parameters, significantly reducing inference costs and improving response speed [9] Commercialization - By the third quarter of 2025, Trizen AI has been widely implemented, reducing inpatient medical record writing time from an average of 10 minutes to 1.8 minutes in some hospitals, with a diagnostic accuracy rate of 93.5% [12] - The company has developed specialized models for different medical fields, including traditional Chinese medicine and pediatrics, enhancing the digital transformation of hospitals [13] Conclusion - Quanzhen Medical represents a new phase in China's medical AI landscape, transitioning from algorithm experimentation to clinical application, aiming to integrate AI capabilities with medical practice [14][15]

Core Viewpoint - The strategic partnership between China Medical Industry Top 100 Company, Good Doctor Group, and AI innovator Hangzhou Quanzhen Medical Technology aims to enhance grassroots healthcare through AI solutions and a joint venture [1][11]. Group 1: Strategic Partnership - Good Doctor Group and Quanzhen Medical will establish a joint venture to provide a comprehensive healthcare management information system (HIS), AI large models (LLM), and a series of medical intelligent agents targeting grassroots healthcare [1]. - The collaboration will leverage Good Doctor Group's extensive market network and Quanzhen Medical's advanced AI model training and application capabilities to develop and deploy leading AI solutions for nearly one million grassroots medical institutions across China [1][11]. Group 2: Leadership and Vision - Good Doctor Group's Chairman, Mr. Geng Funeng, emphasized the importance of enhancing grassroots medical service capabilities as a cornerstone of building a healthy China [7]. - The partnership is seen as a significant step in combining world-class AI technology with strong market implementation capabilities, aiming to deliver top-tier AI intelligence to every grassroots corner in need [7][11]. Group 3: AI Technology Application - Quanzhen Medical's founder, Dr. Xue Chong, highlighted the successful application of their AI product, Trizen AI, in over a hundred top-tier hospitals in China, showcasing the potential for AI to decentralize healthcare [3][11]. - The goal of the collaboration is to create AI medical solutions that are truly applicable to China's grassroots healthcare settings, significantly improving efficiency and accessibility [11]. Group 4: Collaborative Efforts - During the signing ceremony, both parties exchanged constructive opinions and suggestions regarding national research, market, and brand cooperation, indicating a strong commitment to the partnership [12].